Scott Blades is a longtime champion of care for people in the Tucson community who are impacted by HIV and AIDS.

The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents.

Trump's aid cuts impact HIV prevention in Africa, leaving vulnerable groups at risk Trump says U.S. pays too much in foreign aid, wants others to help shoulder burden PEPFAR provision of ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions — although it's unclear how many ...

A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn shrinking health budgets may limit access in high-risk areas.

AHF: Gilead’s Greed Kills Promise of Lenacapavir for HIV PreventionLUBLIN, Poland-- (BUSINESS WIRE)--Join AIDS Healthcare Foundation (AHF) Poland for a Menstrual Health Day commemorative event ...

While a vaccine to prevent HIV still is needed, some experts say the shot made by Gilead Sciences — a drug called lenacapavir — could be the next best thing.

TAMPA, Fla.-- (BUSINESS WIRE)-- On National HIV Testing Day, CAN Community Health is partnering with Walgreens to support the national ‘Greater Than HIV’ campaign. This initiative provides ...

The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding for HIV prevention efforts.

The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding for HIV prevention efforts.

Named in honor of longtime AIDS advocate Susan Terry, the Foundation reflects her enduring legacy of empathy, service, and commitment to health equity.